Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05399771 · ClinicalTrials.gov registry record · NA

Radiofrequency Hyperthermia Safety Study

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT05399771 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05399771, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This study will include 20 healthy subjects with intact skin on their lower legs that meet inclusion criteria. Participants will serve as their own control, by heating one leg and not the other. The radiofrequency device consists of a 4 by 6 inch heating pad connected to a temperature controller. Subjects will receive weekly treatments for 4 weeks, and will be re-evaluated 4 weeks after the last treatment to assess any tissue changes that continue after the treatments have concluded.

Interventions

  • DEVICE Laser Doppler
  • DEVICE Radiofrequency Heating System
  • DEVICE Thermal Imaging
  • OTHER Healthcare Questionnaire & Measurement

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-06-27
Est. Completion 2023-10-23
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT05399771

The ClinicalTrials.gov registry entry for NCT05399771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Laser Doppler is the first listed.

NCT05399771 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05399771 about?

NCT05399771 is a clinical study titled "Radiofrequency Hyperthermia Safety Study". This study will include 20 healthy subjects with intact skin on their lower legs that meet inclusion criteria. Participants will serve as their own control, by heating one leg and not the other. The radiofrequency device consists of a 4 by 6 inch heating pad connected to a temperature controller. Su...

What is the current status of trial NCT05399771?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-06-27. Estimated completion is 2023-10-23.

What interventions are being tested in trial NCT05399771?

The interventions under investigation include: Laser Doppler (DEVICE), Radiofrequency Heating System (DEVICE), Thermal Imaging (DEVICE), Healthcare Questionnaire & Measurement (OTHER).

Who is sponsoring clinical trial NCT05399771?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.